Health CanadaGeneral Alert
AVANDIA, AVANDAMET and AVANDARYL - Important New Restrictions on the Use of Rosi...
Published: November 18, 2010Recall ID: 25633Category: generalCountry: Canada
Product Description & Identification
AVANDIA, AVANDAMET and AVANDARYL - Important New Restrictions on the Use of Rosiglitazone Products Due to Information on Cardiovascular Related Events - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 25633 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/avandia-avandamet-and-avandaryl-important-new-restrictions-use-rosiglitazone-0 |
| Title | AVANDIA, AVANDAMET and AVANDARYL - Important New Restrictions on the Use of Rosiglitazone Products Due to Information on Cardiovascular Related Events - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2010-11-18 |
| Organization | Marketed health products |